Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01771497 · ClinicalTrials.gov registry record
Koning Breast Computed Tomography Guided Neoadjuvant Treatment Monitoring
A clinical trial, sponsored by Koning Corporation.
- Completed
- Registry status
- 12
- Enrollment target
NCT01771497: Completed study, sponsored by Koning Corporation.
NCT01771497 is a clinical trial that has completed, run by Koning Corporation. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01771497 has completed, sponsored by Koning Corporation.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The hypothesis of this study is that using Koning Breast CT during the neoadjuvant treatment of breast cancer will allow for accurate tumor localization and tumor volume measurement, leading to improved surgical and radiation therapy outcomes.
Primary Outcome
Tumor volume will be measured with KBCT imaging at the beginning of the therapy (baseline), mid-point of the therapy (about 3 months after the treatment starts) and end of therapy (about 4-6 months after the treatment starts). The volume change from the baseline during the treatment will be recorded. Adverse Events will be recorded as a measure of safety.
Interventions
- DEVICE Koning Breast CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2010-07 |
| Est. Completion | 2015-12 |
What the finished NCT01771497 record still lists
NCT01771497 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Koning Breast CT is the first listed.
NCT01771497 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01771497 about?
NCT01771497 is a clinical study titled "Koning Breast Computed Tomography Guided Neoadjuvant Treatment Monitoring". The hypothesis of this study is that using Koning Breast CT during the neoadjuvant treatment of breast cancer will allow for accurate tumor localization and tumor volume measurement, leading to improved surgical and radiation therapy outcomes.
What is the current status of trial NCT01771497?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2010-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01771497?
The interventions under investigation include: Koning Breast CT (DEVICE).
Who is sponsoring clinical trial NCT01771497?
This trial is sponsored by Koning Corporation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia